Renata Pasqualini Selected Research

Cys-Leu-Pro-Arg-Cys (1-5)-disulfide

10/2015

The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renata Pasqualini Research Topics

Disease

99	Neoplasms (Cancer) 10/2023 - 02/2002
23	Neoplasm Metastasis (Metastasis) 10/2023 - 12/2002
16	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 02/2002
9	Infections 06/2021 - 06/2002
8	Breast Neoplasms (Breast Cancer) 07/2021 - 09/2004
7	COVID-19 10/2023 - 01/2021
6	Leukemia 07/2015 - 04/2003
5	Carcinogenesis 01/2023 - 02/2009
5	Melanoma (Melanoma, Malignant) 02/2016 - 10/2008
4	Obesity 01/2020 - 11/2011
4	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 04/2010
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 11/2012
3	Weight Loss (Weight Reduction) 01/2020 - 11/2011
3	Atherosclerosis 12/2018 - 12/2002
3	Inflammation (Inflammations) 10/2017 - 08/2006
3	Osteosarcoma (Osteogenic Sarcoma) 01/2017 - 03/2009
3	Neuroblastoma 10/2015 - 07/2010
3	Lymphoma (Lymphomas) 07/2015 - 04/2008
3	Transitional Cell Carcinoma 01/2015 - 04/2003
3	Hypoxia (Hypoxemia) 02/2014 - 02/2004
3	Emphysema 08/2009 - 08/2006
2	Breakthrough Infections 10/2023 - 01/2023
2	Triple Negative Breast Neoplasms 03/2022 - 01/2021
2	Chagas Disease (American Trypanosomiasis) 12/2021 - 06/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2010
2	Carcinoma (Carcinomatosis) 01/2018 - 04/2003
2	Multiple Myeloma 10/2017 - 01/2004
2	Lung Neoplasms (Lung Cancer) 01/2016 - 03/2015
2	Retinal Diseases 10/2015 - 10/2007
2	Necrosis 06/2013 - 10/2002
2	Disease Progression 05/2011 - 01/2003
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 03/2010 - 10/2007
2	Sarcoma (Soft Tissue Sarcoma) 04/2009 - 03/2008

Drug/Important Bio-Agent (IBA)

46	LigandsIBA 10/2023 - 12/2002
42	Peptides (Polypeptides)IBA 03/2021 - 02/2002
28	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2003
13	Peptide LibraryIBA 12/2021 - 02/2004
11	PeptidomimeticsIBA 01/2017 - 11/2005
10	1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine- vasopressin (AAVP)IBA 03/2021 - 04/2006
10	Endoplasmic Reticulum Chaperone BiPIBA 12/2018 - 09/2004
9	AntibodiesIBA 01/2018 - 02/2002
8	IntegrinsIBA 01/2020 - 08/2004
7	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 09/2004
7	Interleukin-11 Receptors (Interleukin 11 Receptor)IBA 01/2017 - 12/2002
6	CD13 Antigens (Alanine Aminopeptidase)IBA 10/2023 - 12/2002
6	VaccinesIBA 10/2023 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2015
5	AntigensIBA 01/2023 - 07/2010
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2016 - 02/2002
4	EpitopesIBA 06/2021 - 05/2011
4	CytokinesIBA 01/2021 - 01/2008
4	AutoantibodiesIBA 12/2018 - 01/2010
4	Monoclonal AntibodiesIBA 01/2018 - 02/2004
4	bone metastasis-targeting peptidomimetic-11IBA 01/2017 - 07/2015
4	Thymidine KinaseIBA 11/2016 - 03/2008
3	Neutralizing AntibodiesIBA 10/2023 - 06/2021
3	Long Noncoding RNAIBA 01/2023 - 07/2015
3	Cell Surface ReceptorsIBA 01/2017 - 10/2016
3	Liposomes (Liposome)IBA 02/2016 - 07/2010
3	Indicators and Reagents (Reagents)IBA 02/2015 - 11/2005
3	Neoplasm Antigens (Tumor Antigens)IBA 02/2015 - 11/2004
2	mRNA VaccinesIBA 10/2023 - 01/2023
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 02/2014
2	HydrogelsIBA 01/2023 - 02/2016
2	MicroRNAs (MicroRNA)IBA 03/2022 - 06/2010
2	IronIBA 07/2021 - 01/2011
2	InterferonsIBA 02/2021 - 11/2020
2	Cysteine (L-Cysteine)FDA Link 01/2021 - 05/2006
2	Molecular Chaperones (Chaperone, Molecular)IBA 12/2018 - 12/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 07/2016
2	Immunoglobulin G (IgG)IBA 10/2017 - 02/2010
2	Immunoglobulins (Immunoglobulin)IBA 10/2017 - 01/2015
2	Interleukin-11 (Interleukin 11)IBA 01/2017 - 01/2008
2	Myeloblastin (Proteinase 3)IBA 01/2017 - 11/2011
2	Annexin A2 (Annexin II)IBA 01/2017 - 11/2011
2	Ganciclovir (Cytovene)FDA LinkGeneric 11/2016 - 08/2009
2	ProdrugsIBA 11/2016 - 05/2004
2	Silicon Dioxide (Silica)FDA LinkGeneric 10/2016 - 02/2016
2	Antineoplastic Agents (Antineoplastics)IBA 02/2016 - 05/2013
2	Retinaldehyde (Retinal)IBA 10/2015 - 10/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015 - 03/2006
2	AndrogensIBA 03/2015 - 01/2015
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2015 - 05/2013
2	Protein Isoforms (Isoforms)IBA 02/2015 - 02/2002
2	Oxygen (Dioxygen)IBA 02/2014 - 03/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2013 - 07/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2013 - 01/2013
2	Cadherins (E-Cadherin)IBA 11/2012 - 11/2005
2	NGR peptideIBA 09/2012 - 10/2008
2	ErbB Receptors (EGF Receptor)IBA 01/2011 - 03/2010
2	Glutamyl Aminopeptidase (Aspartyl Aminopeptidase)IBA 07/2010 - 02/2004
2	Peptide Hydrolases (Proteases)FDA Link 08/2006 - 02/2004
1	InterleukinsIBA 10/2023

Therapy/Procedure

45	Therapeutics 03/2023 - 02/2002
5	Drug Therapy (Chemotherapy) 01/2021 - 01/2008
4	Immunotherapy 12/2022 - 02/2010
4	Precision Medicine 01/2021 - 08/2016
2	Thyroidectomy 03/2023 - 01/2023
2	Aftercare (After-Treatment) 01/2020 - 09/2011
2	Radiotherapy 03/2015 - 05/2011